Korean Gene, Cell Therapies Edge Ahead In Challenging Environment
This article was originally published in PharmAsia News
Executive Summary
Despite the challenges in the sector, South Korean biotech companies are making substantial progress in the gene and cell therapy space, with several companies set to begin or already in late stage clinical trials at home and abroad, stepping gradually towards commercialization.